BIO-RAD LABORATORIES, INC. — Director's Dealing 2013

Sep 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2013-09-11

Reporting Person: SCHWARTZ NORMAN D (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-12	Bio-Rad B Common Stock	M	2617	—	Acquired	126083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-11	Restricted Stock Units	$0	A	13000	Acquired		Bio-Rad B Common Stock (13000)	Direct
2013-09-11	Non-Qualified Stock Option (right to buy)	$117.50	A	39000	Acquired	2023-09-11	Bio-Rad B Common Stock (39000)	Direct
2013-09-12	Restricted Stock Units	$0	M	2617	Disposed		Bio-Rad B Common Stock (2617)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	411252	Direct
Bio-Rad B Common Stock	12266	Indirect
Bio-Rad B Common Stock	4060054	Indirect
Bio-Rad B Common Stock	13726	Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F4: The shares are held by a limited partnership of which the reporting person is a limited partner.

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F6: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F7: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F8: The restricted stock units vest in five equal annual installments beginning September 12, 2013.